Topics

Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for ...

11:05 EDT 1 Oct 2019 | BioMedReports - Blog

Company secures up to $20 million debt facility with Silicon Valley Bank and Oxford Finance LLC

Company receives exclusive rights to negotiate licensing rights to develop and commercialize itolizumab in select major markets outside of North America

Management to host conference call today, Tuesday, October 1, at 4:30 p.m. ET

LA JOLLA, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for ...

NEXT ARTICLE

More From BioPortfolio on "Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for ..."

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...